Literature DB >> 16557272

Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.

T M Johnson1, L D Attardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16557272     DOI： 10.1038/sj.cdd.4401902

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  9 in total

1.  Characterization of functional domains necessary for mutant p53 gain of function.

Authors:  Wensheng Yan; Xinbin Chen
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

2.  Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.

Authors:  Chul Won Lee; Josephine C Ferreon; Allan Chris M Ferreon; Munehito Arai; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

Review 3.  p53 post-translational modification: deregulated in tumorigenesis.

Authors:  Chao Dai; Wei Gu
Journal:  Trends Mol Med       Date:  2010-11       Impact factor: 11.951

Review 4.  20 years studying p53 functions in genetically engineered mice.

Authors:  Lawrence A Donehower; Guillermina Lozano
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

Review 5.  Modeling the study of DNA damage responses in mice.

Authors:  Julia Specks; Maria Nieto-Soler; Andres J Lopez-Contreras; Oscar Fernandez-Capetillo
Journal:  Methods Mol Biol       Date:  2015

6.  Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.

Authors:  Yi Kong; Yan Zheng; Yanfei Jia; Ping Li; Yunshan Wang
Journal:  Oncol Rep       Date:  2016-08-01       Impact factor: 3.906

7.  CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling.

Authors:  Dongni Chen; Hongli Zhou; Zhuochen Cai; Kaican Cai; Ji Liu; Weidong Wang; Huikai Miao; Hongmu Li; Rongzhen Li; Xiaodong Li; Youfang Chen; Hui-Yun Wang; Zhesheng Wen
Journal:  J Exp Clin Cancer Res       Date:  2022-04-01

8.  Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.

Authors:  D P Teufel; M Bycroft; A R Fersht
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

9.  Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer.

Authors:  Eric Villiard; Henner Brinkmann; Olga Moiseeva; Frédérick A Mallette; Gerardo Ferbeyre; Stéphane Roy
Journal:  BMC Evol Biol       Date:  2007-09-28       Impact factor: 3.260
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.